nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Vismodegib—skin cancer	0.106	0.129	CbGbCtD
Nelfinavir—ABCG2—Vemurafenib—skin cancer	0.0841	0.102	CbGbCtD
Nelfinavir—CYP1A2—Imiquimod—skin cancer	0.0633	0.0768	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—skin cancer	0.0559	0.0678	CbGbCtD
Nelfinavir—CYP2C19—Vismodegib—skin cancer	0.0475	0.0577	CbGbCtD
Nelfinavir—CYP2C9—Vismodegib—skin cancer	0.0395	0.048	CbGbCtD
Nelfinavir—ABCB1—Vismodegib—skin cancer	0.0383	0.0466	CbGbCtD
Nelfinavir—ABCG2—Fluorouracil—skin cancer	0.0378	0.0459	CbGbCtD
Nelfinavir—CYP1A2—Vemurafenib—skin cancer	0.0347	0.0421	CbGbCtD
Nelfinavir—CYP3A4—Imiquimod—skin cancer	0.0331	0.0402	CbGbCtD
Nelfinavir—CYP3A4—Temozolomide—skin cancer	0.0331	0.0402	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—skin cancer	0.0288	0.035	CbGbCtD
Nelfinavir—CYP2D6—Vemurafenib—skin cancer	0.0286	0.0347	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—skin cancer	0.0266	0.0323	CbGbCtD
Nelfinavir—CYP3A4—Vismodegib—skin cancer	0.023	0.0279	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0213	0.0259	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—skin cancer	0.0213	0.0259	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—skin cancer	0.0201	0.0245	CbGbCtD
Nelfinavir—CYP3A4—Vemurafenib—skin cancer	0.0182	0.022	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—skin cancer	0.016	0.0194	CbGbCtD
Nelfinavir—CYP1A2—Fluorouracil—skin cancer	0.0156	0.0189	CbGbCtD
Nelfinavir—CYP2C9—Fluorouracil—skin cancer	0.014	0.017	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—skin cancer	0.0104	0.0126	CbGbCtD
Nelfinavir—CYP3A4—Docetaxel—skin cancer	0.00623	0.00757	CbGbCtD
Nelfinavir—Haemorrhage—Bleomycin—skin cancer	0.000495	0.00281	CcSEcCtD
Nelfinavir—Muscular weakness—Fluorouracil—skin cancer	0.00049	0.00278	CcSEcCtD
Nelfinavir—Neutropenia—Temozolomide—skin cancer	0.000488	0.00277	CcSEcCtD
Nelfinavir—Skin disorder—Imiquimod—skin cancer	0.000481	0.00273	CcSEcCtD
Nelfinavir—Hyperhidrosis—Imiquimod—skin cancer	0.000478	0.00271	CcSEcCtD
Nelfinavir—Anorexia—Imiquimod—skin cancer	0.000472	0.00268	CcSEcCtD
Nelfinavir—Hyperglycaemia—Temozolomide—skin cancer	0.00047	0.00267	CcSEcCtD
Nelfinavir—Pneumonia—Temozolomide—skin cancer	0.000468	0.00265	CcSEcCtD
Nelfinavir—Hepatitis—Dactinomycin—skin cancer	0.000462	0.00262	CcSEcCtD
Nelfinavir—Body temperature increased—Vemurafenib—skin cancer	0.000459	0.0026	CcSEcCtD
Nelfinavir—Pharyngitis—Dactinomycin—skin cancer	0.000458	0.0026	CcSEcCtD
Nelfinavir—Stomatitis—Temozolomide—skin cancer	0.000453	0.00257	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000451	0.00256	CcSEcCtD
Nelfinavir—Insomnia—Imiquimod—skin cancer	0.000448	0.00254	CcSEcCtD
Nelfinavir—Paraesthesia—Imiquimod—skin cancer	0.000444	0.00252	CcSEcCtD
Nelfinavir—Dyspnoea—Imiquimod—skin cancer	0.000441	0.0025	CcSEcCtD
Nelfinavir—Somnolence—Imiquimod—skin cancer	0.00044	0.0025	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Temozolomide—skin cancer	0.00044	0.00249	CcSEcCtD
Nelfinavir—Erythema multiforme—Dactinomycin—skin cancer	0.000436	0.00248	CcSEcCtD
Nelfinavir—Sinusitis—Temozolomide—skin cancer	0.000436	0.00247	CcSEcCtD
Nelfinavir—Dyspepsia—Imiquimod—skin cancer	0.000436	0.00247	CcSEcCtD
Nelfinavir—Pneumonia—Fluorouracil—skin cancer	0.000431	0.00244	CcSEcCtD
Nelfinavir—Erythema—Bleomycin—skin cancer	0.000431	0.00244	CcSEcCtD
Nelfinavir—Decreased appetite—Imiquimod—skin cancer	0.00043	0.00244	CcSEcCtD
Nelfinavir—Hypersensitivity—Vemurafenib—skin cancer	0.000428	0.00243	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Imiquimod—skin cancer	0.000427	0.00242	CcSEcCtD
Nelfinavir—Pain—Imiquimod—skin cancer	0.000423	0.0024	CcSEcCtD
Nelfinavir—Dermatitis bullous—Docetaxel—skin cancer	0.00042	0.00238	CcSEcCtD
Nelfinavir—Haemoglobin—Temozolomide—skin cancer	0.00042	0.00238	CcSEcCtD
Nelfinavir—Stomatitis—Fluorouracil—skin cancer	0.000418	0.00237	CcSEcCtD
Nelfinavir—Haemorrhage—Temozolomide—skin cancer	0.000417	0.00237	CcSEcCtD
Nelfinavir—Hepatitis—Temozolomide—skin cancer	0.000417	0.00237	CcSEcCtD
Nelfinavir—Asthenia—Vemurafenib—skin cancer	0.000416	0.00236	CcSEcCtD
Nelfinavir—Pharyngitis—Temozolomide—skin cancer	0.000414	0.00235	CcSEcCtD
Nelfinavir—Pruritus—Vemurafenib—skin cancer	0.000411	0.00233	CcSEcCtD
Nelfinavir—Connective tissue disorder—Temozolomide—skin cancer	0.00041	0.00233	CcSEcCtD
Nelfinavir—Feeling abnormal—Imiquimod—skin cancer	0.000408	0.00231	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Imiquimod—skin cancer	0.000405	0.0023	CcSEcCtD
Nelfinavir—Epistaxis—Fluorouracil—skin cancer	0.000404	0.00229	CcSEcCtD
Nelfinavir—Sinusitis—Fluorouracil—skin cancer	0.000402	0.00228	CcSEcCtD
Nelfinavir—Erythema—Dactinomycin—skin cancer	0.000402	0.00228	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000401	0.00228	CcSEcCtD
Nelfinavir—Ill-defined disorder—Bleomycin—skin cancer	0.0004	0.00227	CcSEcCtD
Nelfinavir—Anaemia—Bleomycin—skin cancer	0.000398	0.00226	CcSEcCtD
Nelfinavir—Diarrhoea—Vemurafenib—skin cancer	0.000397	0.00225	CcSEcCtD
Nelfinavir—Migraine—Docetaxel—skin cancer	0.000395	0.00224	CcSEcCtD
Nelfinavir—Erythema multiforme—Temozolomide—skin cancer	0.000395	0.00224	CcSEcCtD
Nelfinavir—Urticaria—Imiquimod—skin cancer	0.000393	0.00223	CcSEcCtD
Nelfinavir—Body temperature increased—Imiquimod—skin cancer	0.000391	0.00222	CcSEcCtD
Nelfinavir—Abdominal pain—Imiquimod—skin cancer	0.000391	0.00222	CcSEcCtD
Nelfinavir—Eye disorder—Temozolomide—skin cancer	0.00039	0.00221	CcSEcCtD
Nelfinavir—Malaise—Bleomycin—skin cancer	0.000389	0.0022	CcSEcCtD
Nelfinavir—Haemoglobin—Fluorouracil—skin cancer	0.000387	0.00219	CcSEcCtD
Nelfinavir—Leukopenia—Bleomycin—skin cancer	0.000386	0.00219	CcSEcCtD
Nelfinavir—Rhinitis—Fluorouracil—skin cancer	0.000386	0.00219	CcSEcCtD
Nelfinavir—Haemorrhage—Fluorouracil—skin cancer	0.000385	0.00218	CcSEcCtD
Nelfinavir—Dizziness—Vemurafenib—skin cancer	0.000384	0.00218	CcSEcCtD
Nelfinavir—Pharyngitis—Fluorouracil—skin cancer	0.000382	0.00217	CcSEcCtD
Nelfinavir—Angiopathy—Temozolomide—skin cancer	0.000379	0.00215	CcSEcCtD
Nelfinavir—Immune system disorder—Temozolomide—skin cancer	0.000377	0.00214	CcSEcCtD
Nelfinavir—Dehydration—Docetaxel—skin cancer	0.000373	0.00212	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dactinomycin—skin cancer	0.000373	0.00211	CcSEcCtD
Nelfinavir—Anaemia—Dactinomycin—skin cancer	0.000371	0.00211	CcSEcCtD
Nelfinavir—Liver function test abnormal—Docetaxel—skin cancer	0.000371	0.0021	CcSEcCtD
Nelfinavir—Vomiting—Vemurafenib—skin cancer	0.000369	0.00209	CcSEcCtD
Nelfinavir—Myalgia—Bleomycin—skin cancer	0.000367	0.00208	CcSEcCtD
Nelfinavir—Abdominal pain upper—Docetaxel—skin cancer	0.000367	0.00208	CcSEcCtD
Nelfinavir—Rash—Vemurafenib—skin cancer	0.000366	0.00208	CcSEcCtD
Nelfinavir—Dermatitis—Vemurafenib—skin cancer	0.000366	0.00207	CcSEcCtD
Nelfinavir—Hypersensitivity—Imiquimod—skin cancer	0.000365	0.00207	CcSEcCtD
Nelfinavir—Headache—Vemurafenib—skin cancer	0.000364	0.00206	CcSEcCtD
Nelfinavir—Erythema—Temozolomide—skin cancer	0.000363	0.00206	CcSEcCtD
Nelfinavir—Malnutrition—Temozolomide—skin cancer	0.000363	0.00206	CcSEcCtD
Nelfinavir—Discomfort—Bleomycin—skin cancer	0.000362	0.00206	CcSEcCtD
Nelfinavir—Malaise—Dactinomycin—skin cancer	0.000362	0.00206	CcSEcCtD
Nelfinavir—Cramp muscle—Docetaxel—skin cancer	0.000361	0.00205	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000361	0.00205	CcSEcCtD
Nelfinavir—Leukopenia—Dactinomycin—skin cancer	0.00036	0.00204	CcSEcCtD
Nelfinavir—Asthenia—Imiquimod—skin cancer	0.000355	0.00201	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000354	0.00201	CcSEcCtD
Nelfinavir—Oedema—Bleomycin—skin cancer	0.000352	0.00199	CcSEcCtD
Nelfinavir—Back pain—Temozolomide—skin cancer	0.000352	0.00199	CcSEcCtD
Nelfinavir—Pruritus—Imiquimod—skin cancer	0.00035	0.00199	CcSEcCtD
Nelfinavir—Nausea—Vemurafenib—skin cancer	0.000345	0.00196	CcSEcCtD
Nelfinavir—Thrombocytopenia—Bleomycin—skin cancer	0.000344	0.00195	CcSEcCtD
Nelfinavir—Myalgia—Dactinomycin—skin cancer	0.000342	0.00194	CcSEcCtD
Nelfinavir—Bronchospasm—Docetaxel—skin cancer	0.000341	0.00194	CcSEcCtD
Nelfinavir—Diarrhoea—Imiquimod—skin cancer	0.000339	0.00192	CcSEcCtD
Nelfinavir—Discomfort—Dactinomycin—skin cancer	0.000338	0.00192	CcSEcCtD
Nelfinavir—Ill-defined disorder—Temozolomide—skin cancer	0.000337	0.00191	CcSEcCtD
Nelfinavir—Anaemia—Temozolomide—skin cancer	0.000336	0.00191	CcSEcCtD
Nelfinavir—Anorexia—Bleomycin—skin cancer	0.000335	0.0019	CcSEcCtD
Nelfinavir—Erythema—Fluorouracil—skin cancer	0.000335	0.0019	CcSEcCtD
Nelfinavir—Agitation—Temozolomide—skin cancer	0.000334	0.00189	CcSEcCtD
Nelfinavir—Oedema—Dactinomycin—skin cancer	0.000328	0.00186	CcSEcCtD
Nelfinavir—Malaise—Temozolomide—skin cancer	0.000328	0.00186	CcSEcCtD
Nelfinavir—Dizziness—Imiquimod—skin cancer	0.000327	0.00186	CcSEcCtD
Nelfinavir—Leukopenia—Temozolomide—skin cancer	0.000325	0.00185	CcSEcCtD
Nelfinavir—Neutropenia—Docetaxel—skin cancer	0.000324	0.00184	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dactinomycin—skin cancer	0.000321	0.00182	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00032	0.00182	CcSEcCtD
Nelfinavir—Paraesthesia—Bleomycin—skin cancer	0.000316	0.00179	CcSEcCtD
Nelfinavir—Convulsion—Temozolomide—skin cancer	0.000315	0.00179	CcSEcCtD
Nelfinavir—Vomiting—Imiquimod—skin cancer	0.000315	0.00179	CcSEcCtD
Nelfinavir—Dyspnoea—Bleomycin—skin cancer	0.000313	0.00178	CcSEcCtD
Nelfinavir—Anorexia—Dactinomycin—skin cancer	0.000313	0.00177	CcSEcCtD
Nelfinavir—Rash—Imiquimod—skin cancer	0.000312	0.00177	CcSEcCtD
Nelfinavir—Dermatitis—Imiquimod—skin cancer	0.000312	0.00177	CcSEcCtD
Nelfinavir—Pneumonia—Docetaxel—skin cancer	0.000311	0.00176	CcSEcCtD
Nelfinavir—Headache—Imiquimod—skin cancer	0.00031	0.00176	CcSEcCtD
Nelfinavir—Anaemia—Fluorouracil—skin cancer	0.000309	0.00176	CcSEcCtD
Nelfinavir—Arthralgia—Temozolomide—skin cancer	0.000309	0.00176	CcSEcCtD
Nelfinavir—Myalgia—Temozolomide—skin cancer	0.000309	0.00176	CcSEcCtD
Nelfinavir—Anxiety—Temozolomide—skin cancer	0.000308	0.00175	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000307	0.00174	CcSEcCtD
Nelfinavir—Discomfort—Temozolomide—skin cancer	0.000306	0.00173	CcSEcCtD
Nelfinavir—Decreased appetite—Bleomycin—skin cancer	0.000306	0.00173	CcSEcCtD
Nelfinavir—Stomatitis—Docetaxel—skin cancer	0.000301	0.00171	CcSEcCtD
Nelfinavir—Jaundice—Docetaxel—skin cancer	0.000301	0.00171	CcSEcCtD
Nelfinavir—Pain—Bleomycin—skin cancer	0.000301	0.00171	CcSEcCtD
Nelfinavir—Leukopenia—Fluorouracil—skin cancer	0.0003	0.0017	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000299	0.00169	CcSEcCtD
Nelfinavir—Oedema—Temozolomide—skin cancer	0.000297	0.00168	CcSEcCtD
Nelfinavir—Nausea—Imiquimod—skin cancer	0.000294	0.00167	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Docetaxel—skin cancer	0.000292	0.00166	CcSEcCtD
Nelfinavir—Epistaxis—Docetaxel—skin cancer	0.000292	0.00165	CcSEcCtD
Nelfinavir—Thrombocytopenia—Temozolomide—skin cancer	0.00029	0.00165	CcSEcCtD
Nelfinavir—Convulsion—Fluorouracil—skin cancer	0.00029	0.00165	CcSEcCtD
Nelfinavir—Feeling abnormal—Bleomycin—skin cancer	0.00029	0.00164	CcSEcCtD
Nelfinavir—Skin disorder—Temozolomide—skin cancer	0.000288	0.00163	CcSEcCtD
Nelfinavir—Hyperhidrosis—Temozolomide—skin cancer	0.000287	0.00163	CcSEcCtD
Nelfinavir—Myalgia—Fluorouracil—skin cancer	0.000285	0.00162	CcSEcCtD
Nelfinavir—Decreased appetite—Dactinomycin—skin cancer	0.000285	0.00162	CcSEcCtD
Nelfinavir—Anorexia—Temozolomide—skin cancer	0.000283	0.0016	CcSEcCtD
Nelfinavir—Discomfort—Fluorouracil—skin cancer	0.000282	0.0016	CcSEcCtD
Nelfinavir—Pain—Dactinomycin—skin cancer	0.00028	0.00159	CcSEcCtD
Nelfinavir—Urticaria—Bleomycin—skin cancer	0.000279	0.00158	CcSEcCtD
Nelfinavir—Haemoglobin—Docetaxel—skin cancer	0.000279	0.00158	CcSEcCtD
Nelfinavir—Rhinitis—Docetaxel—skin cancer	0.000278	0.00158	CcSEcCtD
Nelfinavir—Body temperature increased—Bleomycin—skin cancer	0.000278	0.00158	CcSEcCtD
Nelfinavir—Haemorrhage—Docetaxel—skin cancer	0.000278	0.00157	CcSEcCtD
Nelfinavir—Hepatitis—Docetaxel—skin cancer	0.000278	0.00157	CcSEcCtD
Nelfinavir—Pharyngitis—Docetaxel—skin cancer	0.000276	0.00156	CcSEcCtD
Nelfinavir—Oedema—Fluorouracil—skin cancer	0.000273	0.00155	CcSEcCtD
Nelfinavir—Connective tissue disorder—Docetaxel—skin cancer	0.000273	0.00155	CcSEcCtD
Nelfinavir—Feeling abnormal—Dactinomycin—skin cancer	0.00027	0.00153	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00027	0.00153	CcSEcCtD
Nelfinavir—Insomnia—Temozolomide—skin cancer	0.000268	0.00152	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dactinomycin—skin cancer	0.000268	0.00152	CcSEcCtD
Nelfinavir—Thrombocytopenia—Fluorouracil—skin cancer	0.000268	0.00152	CcSEcCtD
Nelfinavir—Paraesthesia—Temozolomide—skin cancer	0.000266	0.00151	CcSEcCtD
Nelfinavir—Dyspnoea—Temozolomide—skin cancer	0.000264	0.0015	CcSEcCtD
Nelfinavir—Somnolence—Temozolomide—skin cancer	0.000264	0.0015	CcSEcCtD
Nelfinavir—Erythema multiforme—Docetaxel—skin cancer	0.000263	0.00149	CcSEcCtD
Nelfinavir—Dyspepsia—Temozolomide—skin cancer	0.000261	0.00148	CcSEcCtD
Nelfinavir—Anorexia—Fluorouracil—skin cancer	0.00026	0.00148	CcSEcCtD
Nelfinavir—Eye disorder—Docetaxel—skin cancer	0.000259	0.00147	CcSEcCtD
Nelfinavir—Abdominal pain—Dactinomycin—skin cancer	0.000259	0.00147	CcSEcCtD
Nelfinavir—Body temperature increased—Dactinomycin—skin cancer	0.000259	0.00147	CcSEcCtD
Nelfinavir—Hypersensitivity—Bleomycin—skin cancer	0.000259	0.00147	CcSEcCtD
Nelfinavir—Decreased appetite—Temozolomide—skin cancer	0.000258	0.00146	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Temozolomide—skin cancer	0.000256	0.00145	CcSEcCtD
Nelfinavir—Pain—Temozolomide—skin cancer	0.000254	0.00144	CcSEcCtD
Nelfinavir—Asthenia—Bleomycin—skin cancer	0.000252	0.00143	CcSEcCtD
Nelfinavir—Angiopathy—Docetaxel—skin cancer	0.000252	0.00143	CcSEcCtD
Nelfinavir—Immune system disorder—Docetaxel—skin cancer	0.000251	0.00142	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000249	0.00141	CcSEcCtD
Nelfinavir—Pruritus—Bleomycin—skin cancer	0.000249	0.00141	CcSEcCtD
Nelfinavir—Insomnia—Fluorouracil—skin cancer	0.000247	0.0014	CcSEcCtD
Nelfinavir—Paraesthesia—Fluorouracil—skin cancer	0.000245	0.00139	CcSEcCtD
Nelfinavir—Feeling abnormal—Temozolomide—skin cancer	0.000244	0.00139	CcSEcCtD
Nelfinavir—Dyspnoea—Fluorouracil—skin cancer	0.000244	0.00138	CcSEcCtD
Nelfinavir—Somnolence—Fluorouracil—skin cancer	0.000243	0.00138	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Temozolomide—skin cancer	0.000243	0.00138	CcSEcCtD
Nelfinavir—Malnutrition—Docetaxel—skin cancer	0.000242	0.00137	CcSEcCtD
Nelfinavir—Erythema—Docetaxel—skin cancer	0.000242	0.00137	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—skin cancer	0.000242	0.00137	CcSEcCtD
Nelfinavir—Dyspepsia—Fluorouracil—skin cancer	0.000241	0.00136	CcSEcCtD
Nelfinavir—Decreased appetite—Fluorouracil—skin cancer	0.000238	0.00135	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000236	0.00134	CcSEcCtD
Nelfinavir—Urticaria—Temozolomide—skin cancer	0.000236	0.00134	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—skin cancer	0.000235	0.00133	CcSEcCtD
Nelfinavir—Abdominal pain—Temozolomide—skin cancer	0.000234	0.00133	CcSEcCtD
Nelfinavir—Body temperature increased—Temozolomide—skin cancer	0.000234	0.00133	CcSEcCtD
Nelfinavir—Back pain—Docetaxel—skin cancer	0.000234	0.00133	CcSEcCtD
Nelfinavir—Pain—Fluorouracil—skin cancer	0.000234	0.00133	CcSEcCtD
Nelfinavir—Muscle spasms—Docetaxel—skin cancer	0.000232	0.00132	CcSEcCtD
Nelfinavir—Feeling abnormal—Fluorouracil—skin cancer	0.000225	0.00128	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—skin cancer	0.000224	0.00127	CcSEcCtD
Nelfinavir—Vomiting—Bleomycin—skin cancer	0.000224	0.00127	CcSEcCtD
Nelfinavir—Anaemia—Docetaxel—skin cancer	0.000223	0.00127	CcSEcCtD
Nelfinavir—Rash—Bleomycin—skin cancer	0.000222	0.00126	CcSEcCtD
Nelfinavir—Dermatitis—Bleomycin—skin cancer	0.000221	0.00126	CcSEcCtD
Nelfinavir—Hypersensitivity—Temozolomide—skin cancer	0.000219	0.00124	CcSEcCtD
Nelfinavir—Urticaria—Fluorouracil—skin cancer	0.000217	0.00123	CcSEcCtD
Nelfinavir—Leukopenia—Docetaxel—skin cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Body temperature increased—Fluorouracil—skin cancer	0.000216	0.00123	CcSEcCtD
Nelfinavir—Asthenia—Temozolomide—skin cancer	0.000213	0.00121	CcSEcCtD
Nelfinavir—Pruritus—Temozolomide—skin cancer	0.00021	0.00119	CcSEcCtD
Nelfinavir—Convulsion—Docetaxel—skin cancer	0.000209	0.00119	CcSEcCtD
Nelfinavir—Nausea—Bleomycin—skin cancer	0.000209	0.00118	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—skin cancer	0.000209	0.00118	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—skin cancer	0.000207	0.00117	CcSEcCtD
Nelfinavir—Myalgia—Docetaxel—skin cancer	0.000206	0.00117	CcSEcCtD
Nelfinavir—Arthralgia—Docetaxel—skin cancer	0.000206	0.00117	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000204	0.00116	CcSEcCtD
Nelfinavir—Diarrhoea—Temozolomide—skin cancer	0.000203	0.00115	CcSEcCtD
Nelfinavir—Hypersensitivity—Fluorouracil—skin cancer	0.000201	0.00114	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—skin cancer	0.000197	0.00112	CcSEcCtD
Nelfinavir—Dizziness—Temozolomide—skin cancer	0.000196	0.00111	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—skin cancer	0.000195	0.0011	CcSEcCtD
Nelfinavir—Pruritus—Fluorouracil—skin cancer	0.000193	0.0011	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—skin cancer	0.000193	0.0011	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—skin cancer	0.000192	0.00109	CcSEcCtD
Nelfinavir—Vomiting—Temozolomide—skin cancer	0.000189	0.00107	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—skin cancer	0.000188	0.00107	CcSEcCtD
Nelfinavir—Rash—Temozolomide—skin cancer	0.000187	0.00106	CcSEcCtD
Nelfinavir—Diarrhoea—Fluorouracil—skin cancer	0.000187	0.00106	CcSEcCtD
Nelfinavir—Dermatitis—Temozolomide—skin cancer	0.000187	0.00106	CcSEcCtD
Nelfinavir—Headache—Temozolomide—skin cancer	0.000186	0.00105	CcSEcCtD
Nelfinavir—Dizziness—Fluorouracil—skin cancer	0.000181	0.00103	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00018	0.00102	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—skin cancer	0.000178	0.00101	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—skin cancer	0.000177	0.001	CcSEcCtD
Nelfinavir—Nausea—Temozolomide—skin cancer	0.000176	0.000999	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—skin cancer	0.000176	0.000997	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—skin cancer	0.000175	0.000995	CcSEcCtD
Nelfinavir—Vomiting—Fluorouracil—skin cancer	0.000174	0.000986	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—skin cancer	0.000174	0.000985	CcSEcCtD
Nelfinavir—Rash—Fluorouracil—skin cancer	0.000172	0.000977	CcSEcCtD
Nelfinavir—Dermatitis—Fluorouracil—skin cancer	0.000172	0.000976	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—skin cancer	0.000171	0.000973	CcSEcCtD
Nelfinavir—Headache—Fluorouracil—skin cancer	0.000171	0.000971	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—skin cancer	0.00017	0.000966	CcSEcCtD
Nelfinavir—Pain—Docetaxel—skin cancer	0.000169	0.000957	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—skin cancer	0.000163	0.000922	CcSEcCtD
Nelfinavir—Nausea—Fluorouracil—skin cancer	0.000162	0.000921	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—skin cancer	0.000161	0.000915	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—skin cancer	0.000156	0.000884	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—skin cancer	0.000156	0.000884	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—skin cancer	0.000145	0.000824	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—skin cancer	0.000142	0.000803	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—skin cancer	0.00014	0.000792	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—skin cancer	0.000135	0.000766	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—skin cancer	0.00013	0.00074	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—skin cancer	0.000125	0.000711	CcSEcCtD
Nelfinavir—Rash—Docetaxel—skin cancer	0.000124	0.000705	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—skin cancer	0.000124	0.000705	CcSEcCtD
Nelfinavir—Headache—Docetaxel—skin cancer	0.000124	0.000701	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—skin cancer	0.000117	0.000665	CcSEcCtD
